Filtrovat podle Last updated date SelectpopředFrom - To Datum Datum ukončení Tento týden Tento měsíc Minulý týden Minulý měsíc Category HumanCorporateVeterinaryHerbal Topic MedicinesCOVID-19PharmacovigilanceVaccinesReferralsPaediatricsRare diseasesRegulatory and procedural guidanceClinical trialsAdvanced therapiesData on medicinesCompliance and inspectionsInnovationResearch and developmentMedicine shortagesBiosimilarsSMEAntimicrobial resistanceGovernanceBrexitQuality of medicinesCorporateGeneric and hybrid medicinesEarly accessMedicines for use outside the EUFeesProduct informationMedical devicesScientific adviceMaximum residue limitMpoxBiologicalsScientific guidelinesVeterinary limited marketsCompassionate useCareersMedication errorParallel distributionPRIMEProcurement Diseases area Viral diseasesCancerImmune-system diseasesDiabetesNeurodegenerative diseasesCardiovascular diseasesHIV and AIDS Responsible body CHMP CVMP PRAC Management Board COMP PDCO CMDh HMPC CAT Patient safety Yes Leave this field blank Filter Výsledky (3794) Sort by Last update date (new to old)Last update date (old to new)A-ZZ-A Leave this field blank Regulatory information – adjusted fees for pharmacovigilance applications from 3 October 2022 30 Září 2022 News Corporate New recommendations for terlipressin-containing medicines in the treatment of hepatorenal syndrome 30 Září 2022 News Human Medicines Referrals Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 26-29 September 2022 30 Září 2022 News Human Pharmacovigilance Referrals EMA pilot offers enhanced support to academic and non-profit developers of advanced therapy medicinal products 29 Září 2022 News Human Advanced therapies Medicines New co-chairs elected for working parties for healthcare professionals and for patients and consumers 23 Září 2022 News Corporate Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 12-15 September 2022 22 Září 2022 News Human COVID-19 Medicines Biosimilar medicines can be interchanged 19 Září 2022 News Human Corporate Biosimilars New medicine to protect babies and infants from respiratory syncytial virus (RSV) infection 16 Září 2022 News Human Medicines EMA recommends standard marketing authorisations for Comirnaty and Spikevax COVID-19 vaccines 16 Září 2022 News Human COVID-19 Vaccines Adapted vaccine targeting BA.4 and BA.5 Omicron variants and original SARS-CoV-2 recommended for approval 12 Září 2022 News Human COVID-19 Vaccines 1 … 35 36 37 38 39 Page 39 of 380 40 41 42 43 … 380
Regulatory information – adjusted fees for pharmacovigilance applications from 3 October 2022 30 Září 2022 News Corporate
New recommendations for terlipressin-containing medicines in the treatment of hepatorenal syndrome 30 Září 2022 News Human Medicines Referrals
Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 26-29 September 2022 30 Září 2022 News Human Pharmacovigilance Referrals
EMA pilot offers enhanced support to academic and non-profit developers of advanced therapy medicinal products 29 Září 2022 News Human Advanced therapies Medicines
New co-chairs elected for working parties for healthcare professionals and for patients and consumers 23 Září 2022 News Corporate
Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 12-15 September 2022 22 Září 2022 News Human COVID-19 Medicines
New medicine to protect babies and infants from respiratory syncytial virus (RSV) infection 16 Září 2022 News Human Medicines
EMA recommends standard marketing authorisations for Comirnaty and Spikevax COVID-19 vaccines 16 Září 2022 News Human COVID-19 Vaccines
Adapted vaccine targeting BA.4 and BA.5 Omicron variants and original SARS-CoV-2 recommended for approval 12 Září 2022 News Human COVID-19 Vaccines